155 related articles for article (PubMed ID: 33022187)
21. [Refractory Dyspnea in Advanced COPD: Palliative Treatment with Opioids].
Ficker JH; Brückl WM
Pneumologie; 2019 Jul; 73(7):430-438. PubMed ID: 31291670
[TBL] [Abstract][Full Text] [Related]
22. Opioids for treating refractory dyspnea in patients with heart failure: A protocol for systematic review and meta-analysis: Retraction.
Medicine (Baltimore); 2023 Jul; 102(27):e34401. PubMed ID: 37417643
[No Abstract] [Full Text] [Related]
23. Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease.
Rocker G; Young J; Donahue M; Farquhar M; Simpson C
CMAJ; 2012 Jun; 184(9):E497-504. PubMed ID: 22529167
[TBL] [Abstract][Full Text] [Related]
24. Palliation of dyspnoea in advanced COPD: revisiting a role for opioids.
Rocker G; Horton R; Currow D; Goodridge D; Young J; Booth S
Thorax; 2009 Oct; 64(10):910-5. PubMed ID: 19786716
[TBL] [Abstract][Full Text] [Related]
25. The role of inhaled opioids and furosemide for the treatment of dyspnea.
Kallet RH
Respir Care; 2007 Jul; 52(7):900-10. PubMed ID: 17594733
[TBL] [Abstract][Full Text] [Related]
26. Using opioids to treat dyspnea in advanced COPD: attitudes and experiences of family physicians and respiratory therapists.
Young J; Donahue M; Farquhar M; Simpson C; Rocker G
Can Fam Physician; 2012 Jul; 58(7):e401-7. PubMed ID: 22798476
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological management of dyspnoea.
Currow DC; Abernethy AP
Curr Opin Support Palliat Care; 2007 Aug; 1(2):96-101. PubMed ID: 18685349
[TBL] [Abstract][Full Text] [Related]
28. Junior doctors' attitudes to opioids for refractory breathlessness in patients with advanced chronic obstructive pulmonary disease.
Smallwood N; Gaffney N; Gorelik A; Irving L; Le B; Philip J
Intern Med J; 2017 Sep; 47(9):1050-1056. PubMed ID: 28585274
[TBL] [Abstract][Full Text] [Related]
29. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review.
Ekström M; Nilsson F; Abernethy AA; Currow DC
Ann Am Thorac Soc; 2015 Jul; 12(7):1079-92. PubMed ID: 25803110
[TBL] [Abstract][Full Text] [Related]
30. Re: Liu et al., Effectiveness and safety of opioids on breathlessness and exercise endurance in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis of randomised controlled trials.
Johnson MJ; Ekström M; Janssen DJ; Currow DC
Palliat Med; 2024 Mar; 38(3):400-401. PubMed ID: 38415671
[No Abstract] [Full Text] [Related]
31. Opioid Prescription Method for Breathlessness Due to Non-Cancer Chronic Respiratory Diseases: A Systematic Review.
Yamaguchi Y; Saif-Ur-Rahman KM; Nomura M; Ohta H; Hirakawa Y; Yamanaka T; Hirahara S; Miura H
Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457773
[TBL] [Abstract][Full Text] [Related]
32. The need to address increasing opioid use in elderly COPD patients.
Vozoris NT; O'Donnell DE
Expert Rev Respir Med; 2016; 10(3):245-8. PubMed ID: 26783198
[No Abstract] [Full Text] [Related]
33. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease.
Smallwood N; Le B; Currow D; Irving L; Philip J
Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621
[TBL] [Abstract][Full Text] [Related]
34. A critical review of the respiratory benefits and harms of orally administered opioids for dyspnea management in COPD.
Vozoris NT
Expert Rev Respir Med; 2021 Dec; 15(12):1579-1587. PubMed ID: 34761704
[TBL] [Abstract][Full Text] [Related]
35. A randomized controlled trial on the benefits and respiratory adverse effects of morphine for refractory dyspnea in patients with COPD: Protocol of the MORDYC study.
Verberkt CA; van den Beuken-van Everdingen MH; Franssen FM; Dirksen CD; Schols JM; Wouters EF; Janssen DJ
Contemp Clin Trials; 2016 Mar; 47():228-34. PubMed ID: 26825021
[TBL] [Abstract][Full Text] [Related]
36. Morphine for management of refractory dyspnoea: opiates should be used with caution.
Berrill JW; Linnasne SJ
BMJ; 2003 Nov; 327(7426):1288; author reply 1288-9. PubMed ID: 14644985
[No Abstract] [Full Text] [Related]
37. The use of opioids for dyspnea in advanced disease.
Gallagher R
CMAJ; 2011 Jul; 183(10):1170. PubMed ID: 21746829
[No Abstract] [Full Text] [Related]
38. Opioids for chronic refractory breathlessness: patient predictors of beneficial response.
Johnson MJ; Bland JM; Oxberry SG; Abernethy AP; Currow DC
Eur Respir J; 2013 Sep; 42(3):758-66. PubMed ID: 23258776
[TBL] [Abstract][Full Text] [Related]
39. The role of benzodiazepines in breathlessness: a single site, open label pilot of sustained release morphine together with clonazepam.
Allcroft P; Margitanovic V; Greene A; Agar MR; Clark K; Abernethy AP; Currow DC
J Palliat Med; 2013 Jul; 16(7):741-4. PubMed ID: 23597092
[TBL] [Abstract][Full Text] [Related]
40. Opioids in chronic obstructive pulmonary disease: the whole picture using all available evidence.
Currow DC; Ekström M; Johnson MJ
Br J Clin Pharmacol; 2016 Apr; 81(4):795-6. PubMed ID: 26607043
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
